EV/EBITDA:
-2.89-0.04(-1.40%)Summary
- As of today, MLTX EV/EBITDA is -2.89, with a fall of -0.04 (-1.40%) during the current trading session.
- Over the past year, MLTX EV/EBITDA has increased by +21.27 (+88.04%).
- MLTX EV/EBITDA is now -1104.17% below its all-time high of -0.24.
Performance
MLTX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
MLTX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise ValueEnterprise Value | PricePrice |
|---|---|---|---|
| 1D1 Day | -1.4% | +1.2% | +0.8% |
| 1M1 Month | -136.9% | +136.2% | +48.1% |
| 3M3 Months | +80.8% | -78.2% | -74.3% |
| 6M6 Months | +76.6% | -68.7% | -65.5% |
| YTDYTD | +86.2% | -78.0% | -75.0% |
| 1Y1 Year | +88.0% | -75.1% | -72.6% |
| 5Y5 Years | - | +420.1% | +28.5% |
MLTX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | -1.22 | -136.9% | -2.89 | at low |
| 3M | 3-Month | -0.24 | -1104.2% | -18.08 | +84.0% |
| 6M | 6-Month | -0.24 | -1104.2% | -18.08 | +84.0% |
| 1Y | 1-Year | -0.24 | -1104.2% | -28.21 | +89.8% |
| 3Y | 3-Year | -0.24 | -1104.2% | -61.99 | +95.3% |
| 5Y | 5-Year | -0.24 | -1104.2% | -1492 | +99.8% |
| All-Time | All-Time | -0.24 | -1104.2% | -1492 | +99.8% |
MLTX EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -2.89(+86.2%) |
| 2024 | -20.96(+63.9%) |
| 2023 | -58.11(-1019.7%) |
| Date | Value |
|---|---|
| 2022 | -5.19(-121.8%) |
| 2021 | -2.34(+99.8%) |
| 2020 | -1333.00 |
FAQ
- What is MoonLake Immunotherapeutics EV/EBITDA?
- What is the all-time high EV/EBITDA for MoonLake Immunotherapeutics?
- What is MLTX EV/EBITDA year-to-date change?
- What is MoonLake Immunotherapeutics EV/EBITDA year-on-year change?
What is MoonLake Immunotherapeutics EV/EBITDA?
The current EV/EBITDA of MLTX is -2.89
What is the all-time high EV/EBITDA for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high EV/EBITDA is -0.24
What is MLTX EV/EBITDA year-to-date change?
MoonLake Immunotherapeutics EV/EBITDA has changed by +18.07 (+86.21%) since the beginning of the year
What is MoonLake Immunotherapeutics EV/EBITDA year-on-year change?
Over the past year, MLTX EV/EBITDA has changed by +21.27 (+88.04%)